1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014

Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014" provides data on the Gastrointestinal Tract Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastrointestinal Tract Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastrointestinal Tract Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Gastrointestinal Tract Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Gastrointestinal Tract Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Gastrointestinal Tract Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Gastrointestinal Tract Cancer 25
Subjects Recruited Over a Period of Time 77
Clinical Trials by Sponsor Type 78
Prominent Sponsors 79
Top Companies Participating in Gastrointestinal Tract Cancer Therapeutics Clinical Trials 80
Prominent Drugs 82
Latest Clinical Trials News on Gastrointestinal Tract Cancer 83
Jul 11, 2013: Measles virus improves radiotherapy treatment 83
Aug 27, 2012: pH-sensitive Liposomal Cisplatin Improves Peritoneal Carcinomatosis Treatment Without Side-Effects, Scientists Report 84
Jan 12, 2011: Medimmune And Micromet Initiate Phase I Trial Of MT111 In Advanced Gastrointestinal Cancers 84
Nov 18, 2010: AVEO's Tivozanib In Combination With FOLFOX6 Demonstrates Anti-tumor Activity And Safety In Advanced Gastrointestinal Cancers 85
Nov 03, 2008: Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN And Docetaxel Results at iSBTc Annual Meeting For The Trial REO 010 85
Clinical Trial Profiles 87
Clinical Trial Overview of Top Companies 87
F. Hoffmann-La Roche Ltd. 87
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 87
Sanofi 111
Clinical Trial Overview of Sanofi 111
Pfizer Inc. 124
Clinical Trial Overview of Pfizer Inc. 124
Novartis AG 133
Clinical Trial Overview of Novartis AG 133
Eli Lilly and Company 142
Clinical Trial Overview of Eli Lilly and Company 142
Bayer AG 150
Clinical Trial Overview of Bayer AG 150
AstraZeneca PLC 157
Clinical Trial Overview of AstraZeneca PLC 157
Amgen Inc. 164
Clinical Trial Overview of Amgen Inc. 164
Otsuka Holdings Co., Ltd. 170
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 170
Bristol-Myers Squibb Company 177
Clinical Trial Overview of Bristol-Myers Squibb Company 177
Clinical Trial Overview of Top Institutes / Government 183
National Cancer Institute 183
Clinical Trial Overview of National Cancer Institute 183
Memorial Sloan Kettering Cancer Center 238
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 238
The University of Texas M. D. Anderson Cancer Center 251
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 251
European Organization for Research and Treatment of Cancer 259
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 259
FUDAN University 266
Clinical Trial Overview of FUDAN University 266
Sun Yat-sen University 271
Clinical Trial Overview of Sun Yat-sen University 271
National Cancer Center Hospital 276
Clinical Trial Overview of National Cancer Center Hospital 276
Roswell Park Cancer Institute 280
Clinical Trial Overview of Roswell Park Cancer Institute 280
Sidney Kimmel Comprehensive Cancer Center 285
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 285
Mayo Clinic 290
Clinical Trial Overview of Mayo Clinic 290
Five Key Clinical Profiles 294
Appendix 410
Abbreviations 410
Definitions 410
Research Methodology 411
Secondary Research 411
About GlobalData 412
Contact Us 412
Disclaimer 412
Source 413

List of Tables
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Gastrointestinal Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Gastrointestinal Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Gastrointestinal Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Gastrointestinal Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Gastrointestinal Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Gastrointestinal Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Gastrointestinal Tract Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Gastrointestinal Tract Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 29
Gastrointestinal Tract Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 36
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 77
Gastrointestinal Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 78
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 79
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 81
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 82
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 87
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 111
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 124
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 133
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 142
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 150
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 157
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 164
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 170
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 177
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 183
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 238
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 251
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 259
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014* 266
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 271
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2014* 276
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014* 280
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014* 285
Gastrointestinal Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 290

List of Figures
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Gastrointestinal Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Gastrointestinal Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Gastrointestinal Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Gastrointestinal Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Gastrointestinal Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Gastrointestinal Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Gastrointestinal Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 77
Gastrointestinal Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 78
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 79
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 80
Gastrointestinal Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 82
GlobalData Methodology 411

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.